Ovarian Monodermal and Highly Specialized Teratoma

Explore clinical trials studying Ovarian Monodermal and Highly Specialized Teratoma. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Ovarian Monodermal and Highly Specialized Teratoma trial results

Completed

Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer

NCT01037790

Conditions: Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Adult Central Nervous System Germ Cell Tumor, +74 more
Locations: Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer

NCT00060372

Conditions: Adnexal Diseases, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +148 more
Locations: Scripps Clinic - La Jolla La Jolla, California, United States

University of California San Diego La Jolla, California, United States

Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States

Northside Hospital Atlanta, Georgia, United States

View Trial Details

Ovarian Monodermal and Highly Specialized Teratoma

Ovarian Monodermal and Highly Specialized Teratoma trial results

Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer

Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer

Related conditions